What are the treatment options for Granulomatosis with Polyangiitis (GPA)?

Treatment for Granulomatosis with Polyangiitis (GPA) relies on potent medications that suppress the immune system to reduce inflammation and protect vital organs from damage. Because this condition affects blood vessels in multiple areas such as the lungs, kidneys, and sinuses, prompt medical intervention is essential to improve health outcomes [2]. Treatment is not merely a single dose, but a structured process aimed at first controlling the disease, then maintaining its stability in the long term.

Induction Therapy (Disease Control Phase)

The first step in treating active and severe cases of GPA is to quickly suppress inflammation. The choice of medication depends on the severity of symptoms and the organs involved:

• Corticosteroids: Used to reduce inflammation rapidly.
• Specialized Immunosuppressants: In severe cases, physicians may prescribe biologic drugs such as Rituximab or Avacopan. Chemical drugs such as Cyclophosphamide may also be used to control aggressive disease activity [3].
• Mild Cases: If the condition is less severe, the medical team may suffice with corticosteroids alongside other immunosuppressants like methotrexate [3].

These medications are managed by specialists to ensure a balance between the benefits of stopping inflammation and the potential risks of these drugs.

Maintenance Therapy

Once the first phase successfully controls inflammation, the patient transitions to a phase aimed at maintaining this state and preventing relapses. During this stage, medication doses are typically reduced, or the patient is switched to other types of preventive treatments. The goal here is to prevent the recurrence of symptoms while minimizing the side effects of the potent medications used previously [3]. If new symptoms appear or previous ones return, the medical team may adjust the treatment plan or restart induction protocols [3].

Monitoring Treatment and Surgical Intervention

Managing GPA requires careful, periodic monitoring. There is no single test that fully determines a patient's response to treatment; rather, physicians rely on a combination of clinical assessment, blood tests (such as the ANCA test which helps monitor the condition), and tests of organ function such as kidney and lung function [1], [3]. Treatment may also include surgical procedures or other interventions in the event of complications, such as airway damage or the need for kidney function support via dialysis or kidney transplantation in advanced cases where the kidneys are severely affected [3].

For more details about this disease, you may review our comprehensive article on Granulomatosis with Polyangiitis (GPA) (Arabic).

When to Seek Emergency Help?

You must immediately head to a doctor or emergency department when noticing symptoms indicating the involvement of vital organs, such as acute shortness of breath, coughing up blood, a sudden decrease in urine volume or presence of blood in it, or severe changes in vision or hearing [1], [3]. These signs require urgent medical evaluation to prevent permanent tissue damage.

Medical references

• Antineutrophil Cytoplasmic Antibodies (ANCA) Test
• Granulomatosis with Polyangiitis
• Granulomatosis with polyangiitis (GPA) - NHS